Valuation: Convatec Group PLC

Market Cap 5.63B 4.95B 4.6B 4.22B 7.93B 542B 8.05B 54.63B 21.34B 267B 21.14B 20.69B 922B P/E 2026 *
20.4x
P/E 2027 * 16x
Enterprise Value 6.83B 6B 5.58B 5.12B 9.62B 658B 9.77B 66.27B 25.89B 323B 25.65B 25.09B 1,118B EV / Sales 2026 *
2.66x
EV / Sales 2027 * 2.44x
Free-Float
95.19%
Yield 2026 *
2.72%
Yield 2027 * 3.05%
1 day+2.63%
1 week+0.95%
Current month+3.45%
1 month+5.12%
3 months-2.50%
6 months-8.95%
Current year-10.48%
1 week 11.24
Extreme 11.24
11.7
1 month 11.14
Extreme 11.14
11.94
Current year 10.45
Extreme 10.45
14.09
1 year 10.45
Extreme 10.45
14.09
3 years 9.9
Extreme 9.9
16.65
5 years 8.69
Extreme 8.69
16.65
10 years 0
Extreme 0
18.52
Manager TitleAgeSince
Chief Executive Officer 62 2025-08-03
Director of Finance/CFO 51 2025-08-03
Chief Operating Officer - 2026-05-31
Director TitleAgeSince
Director/Board Member 71 2017-08-13
Chairman 78 2019-09-29
Director/Board Member 62 2020-03-01
Change 5-day change 1-year change 3-year change Capi.($)
+2.63%+0.95% - - 5.63B
+2.29%+2.36%-18.56%-8.74% 180B
+1.46%+0.01%-10.47%-6.46% 107B
+1.58%+0.65%+6.73%+61.49% 60.29B
-1.13%-2.60%+27.02%+55.00% 50.19B
+2.22%-1.14%-15.63%-44.81% 43.08B
+2.98%-2.61% - - 32.77B
+1.50%-6.67%-19.61%-44.95% 27.61B
-7.67%-8.39%+24.55%-12.97% 23.1B
+1.63%-1.73%-7.11%-8.13% 20.86B
Average +0.75%-2.24%-1.63%-1.20% 60.44B
Weighted average by Cap. +1.29%-0.40%-6.81%+1.11%

Financials

2026 *2027 *
Net sales 2.57B 2.25B 2.1B 1.92B 3.61B 247B 3.67B 24.89B 9.72B 121B 9.63B 9.43B 420B 2.74B 2.4B 2.24B 2.05B 3.85B 264B 3.91B 26.55B 10.37B 130B 10.28B 10.05B 448B
Net income 275M 242M 225M 206M 387M 26.49B 393M 2.67B 1.04B 13.02B 1.03B 1.01B 45.03B 354M 311M 289M 265M 498M 34.08B 506M 3.43B 1.34B 16.75B 1.33B 1.3B 57.93B
Net Debt 1.2B 1.05B 980M 899M 1.69B 116B 1.72B 11.64B 4.55B 56.8B 4.5B 4.41B 196B 1.03B 908M 845M 775M 1.46B 99.61B 1.48B 10.03B 3.92B 48.97B 3.88B 3.8B 169B
Logo Convatec Group PLC
ConvaTec Group Plc specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, and incontinence. The group also offers perfusion devices. Net sales break down by area of activity as follows: - wound care (30.9%): antimicrobial dressings, occlusive dressings, compression bandages, etc.; - ostomy care (27.7%): skin barriers, one-piece bags, 2-piece appliance bags, urostomy bags, etc.; - incontinence care (22%); - infusion (19.4%). At the end of 2025, the group operated 7 production sites worldwide. Net sales are distributed geographically as follows: Europe (29.6%), North Americas (55.7%) and other (14.7%).
Employees
10,910
Date Price Change Volume
26-07-24 US$11.70 +2.63% 16,448
26-07-23 US$11.40 -2.56% 19,240
26-07-22 US$11.70 +0.95% 16,433
26-07-21 US$11.59 -0.94% 53,744
26-07-20 US$11.70 +0.95% 112,589
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
2.882USD
Average target price
3.986USD
Spread / Average Target
+38.32%

Quarterly revenue - Rate of surprise